VITA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.436
EU - Europa 1.438
AS - Asia 1.434
SA - Sud America 169
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
AN - Antartide 1
Totale 6.524
Nazione #
US - Stati Uniti d'America 3.300
CN - Cina 639
RU - Federazione Russa 408
SG - Singapore 399
DE - Germania 235
IT - Italia 218
BR - Brasile 144
CA - Canada 116
UA - Ucraina 115
HK - Hong Kong 102
GB - Regno Unito 99
VN - Vietnam 91
SE - Svezia 83
FR - Francia 76
FI - Finlandia 68
KR - Corea 43
IN - India 40
TR - Turchia 37
IE - Irlanda 27
CZ - Repubblica Ceca 24
PL - Polonia 24
JP - Giappone 23
ZA - Sudafrica 19
MX - Messico 17
ES - Italia 15
BE - Belgio 13
IQ - Iraq 10
EU - Europa 9
AR - Argentina 8
BD - Bangladesh 8
IR - Iran 8
NL - Olanda 7
VE - Venezuela 6
CO - Colombia 5
ID - Indonesia 5
LT - Lituania 5
AT - Austria 4
EG - Egitto 4
IL - Israele 4
UY - Uruguay 4
UZ - Uzbekistan 4
AL - Albania 3
MA - Marocco 3
PK - Pakistan 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
KE - Kenya 2
KG - Kirghizistan 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.524
Città #
Ashburn 302
Jacksonville 289
Woodbridge 228
Chandler 201
Singapore 193
Houston 178
Fairfield 168
San Jose 162
Ann Arbor 146
Dallas 138
Boardman 123
Beijing 106
Wilmington 99
Hong Kong 97
Nanjing 83
Seattle 75
Toronto 75
The Dalles 62
Cambridge 59
Los Angeles 59
New York 56
San Mateo 54
Nanchang 41
Ho Chi Minh City 40
Seoul 38
Columbus 37
Lawrence 36
Princeton 36
Tongling 36
Lauterbourg 33
Düsseldorf 32
Dearborn 30
Helsinki 29
Istanbul 29
Ogden 27
Dublin 25
Lachine 25
Tianjin 23
Buffalo 22
Washington 22
Orem 21
São Paulo 21
Redwood City 20
Shanghai 20
Acquaviva 19
Hebei 19
Hanoi 17
Johannesburg 17
Guangzhou 16
Milan 16
Chicago 15
Santa Clara 15
Tokyo 15
Leawood 14
London 14
Moscow 14
Shenyang 14
Brussels 13
Kunming 13
Bremen 12
Brno 12
Camerino 12
Chennai 12
Jiaxing 12
Changsha 11
Hangzhou 11
Jinan 11
Kraków 10
Mumbai 10
Nürnberg 10
Olomouc 10
Stockholm 10
Warsaw 10
Atlanta 9
Brooklyn 9
Changchun 8
Frankfurt am Main 8
Manchester 8
Montreal 8
San Francisco 8
Ankara 7
Ardabil 7
Augusta 7
Mexico City 7
Munich 7
Sapporo 7
Zhengzhou 7
Monmouth Junction 6
Rio de Janeiro 6
Stuttgart 6
Venezia 6
Wuhan 6
Baghdad 5
Denver 5
Falls Church 5
Rome 5
Verona 5
Cagliari 4
Centro 4
Civitanova Marche 4
Totale 4.154
Nome #
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 248
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 236
5’-deoxy-5’-N-pyrazolyl-N6-substituded adenosine derivates as A1 adenosine receptor agonists: synthesis and antinociception in mice 229
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 228
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 215
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 213
5'-CHLORO-5'-DEOXY-N6-(±)-endo-NORBORNYLADENOSINE, A POTENT AND HIGHLY SELECTIVE HUMAN A1 ADENOSINE RECEPTOR AGONIST, PREVENTS HYPERALGESIA/ALLODYNIA AND EARLY OVER-EXPRESSION OF PRO-APOPTOTIC AND PRO-INFLAMMATORY GENES IN A MICE MODEL OF NEUROPATHIC PAIN 213
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 211
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 210
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 209
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 202
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 201
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 200
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 199
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 196
5'-Chloro-5'-deoxy-N6-(±)-endo-norbornyladenosine, a potent and highly selective human A1 adenosine receptor agonist modulates neuropathic pain in mice. 193
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 190
First TiCl4-Mediated Diastereoslective Reduction of alpha-Nitro Ketones to beta-Nitro Alcohols by BH3.SMe2 183
Affinity and selectivity of tecadenoson, 2-chloro-tecadenoson and 2’-C-methyl analogues at bovine and pig A1 adenosine receptor 181
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 181
Ribose-modified mizoribine analogues: synthesis and biological evaluation 174
3’-C-Methyl-ribosyl nucleosides as cytotoxic compounds 174
Selective inhibition of nicotinamide adenine kinases (NADKs) by compact NAD mimics 171
ADP-, and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 ligands 163
NOVEL 2-SUBSTITUTED 2’/3’-C-METHYL-ADENOSINE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST TRYPANOSOMA BRUCEI 161
Bisphosphonate Derivatives of 2’-C-Methyl-, and 3’-C-Methyl-Adenosine as Ligands at P2Y1 and P2Y2 Receptors 160
EFFECTS OF METAL(III) COORDINATION ON BIOLOGICAL ACTIVITY OF 2,2'-BIPYRIDYL-6-CARBOTHIOAMIDE (BPYTA), A POTENT R2 RIBONUCLEOTIDE REDUCTASE INHIBITOR 160
Synthesis and biological evaluation of (methylene)bisphosphonate derivatives of 2’-C-methyl-, and 3’-C-methyl-adenosine 158
Structure-affinity relathionships of 5'-carbamoyl- and 5'-thionocarbamoyl derivatives of the A1 selective adenosine receptor agonist 2'-MeCCPA as partial A1 agonists 157
Sugar-modified nucleosides: synthesis, conformational analysis and biological evaluation 155
Design, synthesis and biological evaluation of novel inhibitors of NAD kinase 150
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 146
Synthesis and Enzymatic Evaluation of NAD Mimics as Nicotinamide Adenine Dinucleotide Kinase (NADK) Inhibitors 145
Dual-target dimeric molecules with antitumor properties. Synthesis and biological activity of 3’-C-methyladenosine-valproates 141
PROBING BINDING REQUIREMENTS OF NAD KINASE WITH MODIFIED NAD ANALOGUES 135
New N6-substituted adenosine and 3’-C-methyl-adenosine derivatives as antitumor agents 121
Totale 6.609
Categoria #
all - tutte 25.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021217 0 0 0 0 0 0 0 0 0 14 148 55
2021/2022354 25 103 6 20 17 23 11 23 30 26 29 41
2022/2023546 68 15 33 71 53 77 1 41 105 27 38 17
2023/2024476 60 29 34 5 24 77 17 23 39 24 9 135
2024/20251.258 58 28 114 50 53 69 193 290 121 72 61 149
2025/20261.505 95 149 155 260 193 140 229 77 61 146 0 0
Totale 6.609